Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-16
2006-05-16
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S375000, C548S152000, C548S217000
Reexamination Certificate
active
07045539
ABSTRACT:
Compounds of the formula (I) for use as an estrogen receptor-β-selective ligand are described wherein: X is O or S; and R1, R3R6are as described in the specification. The use of these compounds in treating Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis, cardiovascular disease, rheumatoid arthritis and prostate cancer is described; as are processes for making them.
REFERENCES:
patent: 5216110 (1993-06-01), Inbasekaran et al.
patent: 5665737 (1997-09-01), Cavalla et al.
patent: 6153631 (2000-11-01), Petrie et al.
patent: 6420418 (2002-07-01), Hagmann et al.
patent: 2002/0133019 (2002-09-01), Klunk et al.
patent: 0483502 (1995-06-01), None
Kimoto et al. 1998, CAS: 128:291486.
Stevens et al., J. Med. Chem., vol. 37, pp. 1689-1695, 1994.
Bradshaw et al., British Journal of Cancer, vol. 77, No. 5, pp. 745-752, 1998.
Hori et al, Chem. Pharm. Bull., vol. 40, No. 9, pp. 2387-2390, 1995.
Nishi et al, STN International, file CAPLUS, No. 1991:207259, Doc. 114:207259.
Barlaam Bernard
Bernstein Peter
Dantzman Cathy
Warwick Paul
AstraZeneca AB
Shiao Robert
Solola Taofiq
White & Case LLP
LandOfFree
Therapeutic benzoxazole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic benzoxazole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic benzoxazole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3629085